Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH14 1409A

Opportunity Information: Apply for CDC RFA GH14 1409A

The funding opportunity titled "Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a discretionary cooperative agreement issued by the Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH). It is identified as CDC RFA GH14-1409A and is cataloged under CFDA number 93.067. The focus of the opportunity is to support population-based HIV impact assessments in settings where resources are limited, aligning with PEPFAR priorities. In practical terms, this type of opportunity is aimed at generating strong, representative data on HIV at the population level to help guide prevention and treatment strategies, track progress, and measure the real-world impact of HIV programs.

Because the award mechanism is a cooperative agreement rather than a standard grant, recipients should expect substantial involvement from CDC during the project period. Cooperative agreements typically mean the funder is not just providing money but is also actively participating in technical guidance, coordination, and oversight. For projects like population-based HIV impact assessments, that involvement often relates to methodological standards, survey design, laboratory and testing protocols, data management expectations, and alignment with broader national and international HIV monitoring frameworks.

The eligibility criteria are broad and include many types of organizations that could credibly carry out large-scale health assessments or support them through implementation, analysis, or service delivery infrastructure. Eligible applicants include nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in those categories), for-profit entities (including small businesses, and specifically small, minority-, and women-owned businesses), and academic entities such as universities and colleges. It also includes research institutions and hospitals, which are often central partners in HIV surveillance work due to their clinical, laboratory, and analytic capabilities. In addition, community-based organizations and faith-based organizations are eligible, reflecting the reality that local partners often play a key role in community entry, recruitment, outreach, and ensuring culturally appropriate implementation.

Government and tribal entities are explicitly included as eligible applicants. This covers federally recognized or state-recognized American Indian/Alaska Native tribal governments, tribally designated organizations, Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers. State and local governments (and their bona fide agents) are eligible as well, including a detailed list of U.S. territories and freely associated states and territories referenced in the notice (for example, Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Political subdivisions of states may apply in consultation with states, which generally signals an expectation of coordination with statewide public health leadership. Notably, the opportunity is also open to non-domestic (non-U.S.) entities, which fits the PEPFAR context where much of the work is carried out internationally in partner countries.

The posting indicates an original closing date of 2017-11-17 and a creation date of 2017-11-03, placing it in a specific historical funding cycle. The source data lists an award ceiling of 0 and does not specify the expected number of awards, which usually means the public summary record did not include a fixed cap in the field provided or that the ceiling depended on the specific award structure, budget negotiation, or available appropriations at the time. Anyone reviewing this opportunity for planning purposes would typically need to consult the full announcement package or related CDC/Grants.gov materials from that cycle to confirm expected funding levels, project periods, and the precise scope of work.

Overall, this opportunity is about supporting rigorous, population-level assessments to understand HIV burden and program impact in resource-constrained settings under the broader PEPFAR umbrella. The wide eligibility pool suggests CDC anticipated partnerships that could combine survey implementation capacity, laboratory testing expertise, epidemiology and biostatistics, and on-the-ground community engagement, all of which are usually necessary to conduct high-quality population-based HIV impact assessments.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-11-03.
• Applicants must submit their applications by 2017-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH14 1409A

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: